Between 2011–12 and 2023–24, average protein consumption rose marginally by 1–3 grams across rural and urban households. In ...

The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole ...

India's anti-obesity drug market is currently valued at Rs 3,000-3,500 crore & is projected to grow nearly eightfold by 2030, according to market estimates.

Kombucha's popularity in India grows, but scientific evidence lags; new study explores gut microbiome effects for health.

Eli Lilly receives approval for Mounjaro in prefilled Kwikpen as competition intensifies in India's weight-loss drug market ...

Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...

With Novo Nordisk’s Wegovy already in the market, Eli Lilly is stepping up its game with a patient-friendly pen device, ...

Multiple myeloma, a treatable but incurable blood cancer, is rising sharply in India, especially among those over 60. Dr.

India’s drug regulator has approved Eli Lilly and Company’s diabetes and obesity drug Mounjaro in a KwikPen presentation, the ...

A 2025 Lancet obesity forecasting study projects a staggering rise in ... waist to hip ratio will also be screened for kids which is a more accurate assessment. Especially for the Indian population, ...

With PCOS insulin resistance and early diabetes risk Indian women face unique metabolic challenges Here’s what science says ...

Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...